{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:20:47Z","timestamp":1765545647573},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1292,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Procedia in Vaccinology"],"published-print":{"date-parts":[[2010]]},"DOI":"10.1016\/j.provac.2010.11.003","type":"journal-article","created":{"date-parts":[[2010,12,5]],"date-time":"2010-12-05T09:26:51Z","timestamp":1291541211000},"page":"12-18","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Multivalent Vaccine for Lymphatic Filariasis"],"prefix":"10.1016","volume":"3","author":[{"given":"Abhilash","family":"Samykutty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gajalakshmi","family":"Dakshinamoorthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramaswamy","family":"Kalyanasundaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.provac.2010.11.003_bib0005","unstructured":"WHO. Lymphatic filariasis: the disease and its control. Fifth report of the WHO Expert Committee on Filariasis. World Health Organ Tech Rep Ser 1992; 821:1-71."},{"issue":"6","key":"10.1016\/j.provac.2010.11.003_bib0010","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/clpt.2009.16","article-title":"Mass drug administration and integrated control for the world's high-prevalence neglected tropical diseases","volume":"85","author":"Hotez","year":"2009","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.provac.2010.11.003_bib0015","doi-asserted-by":"crossref","unstructured":"Babu BV, Mishra S. Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance. Trans R Soc Trop Med Hyg 2008 Dec;102(12):1207-13.","DOI":"10.1016\/j.trstmh.2008.05.023"},{"key":"10.1016\/j.provac.2010.11.003_bib0020","doi-asserted-by":"crossref","unstructured":"El-Setouhy M, Abd Elaziz KM, Helmy H, Farid HA, Kamal HA, Ramzy RM, et al. The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt. Am J Trop Med Hyg 2007 Dec;77(6):1069-73.","DOI":"10.4269\/ajtmh.2007.77.1069"},{"issue":"1","key":"10.1016\/j.provac.2010.11.003_bib0025","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1179\/000349809X12502035776595","article-title":"The development of albendazole for lymphatic filariasis","volume":"103","author":"Horton","year":"2009","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.provac.2010.11.003_bib0030","doi-asserted-by":"crossref","unstructured":"Schwab AE, Churcher TS, Schwab AJ, Basanez MG, Prichard RK. An analysis of the population genetics of potential multi-drug resistance in Wuchereria bancrofti due to combination chemotherapy. Parasitology [2007] Jul;134(Pt 7):1025-40.","DOI":"10.1017\/S0031182007002363"},{"key":"10.1016\/j.provac.2010.11.003_bib0035","doi-asserted-by":"crossref","unstructured":"Molyneux DH. Filaria control and elimination: diagnostic, monitoring and surveillance needs. Trans R Soc Trop Med Hyg 2009 Apr;103(4):338-41.","DOI":"10.1016\/j.trstmh.2008.12.016"},{"key":"10.1016\/j.provac.2010.11.003_bib0040","doi-asserted-by":"crossref","unstructured":"Bottazzi ME, Miles AP, Diemert D, Hotez PJ. An ounce of prevention on a budget: a nonprofit approach to developing vaccines against neglected diseases. Expert Rev Vaccines 2006 Apr;5(2):189-98.","DOI":"10.1586\/14760584.5.2.189"},{"key":"10.1016\/j.provac.2010.11.003_bib0045","doi-asserted-by":"crossref","unstructured":"Chenthamarakshan V, Reddy MV, Harinath BC. Immunoprophylactic potential of a 120 kDa Brugia malayi adult antigen fraction, BmA-2, in lymphatic filariasis. Parasite Immunol 1995 Jun;17(6):277-85.","DOI":"10.1111\/j.1365-3024.1995.tb00893.x"},{"key":"10.1016\/j.provac.2010.11.003_bib0050","unstructured":"Dissanayake S, Perler FB, Xu M, Southworth MW, Yee CK, Wang S, et al. Differential recognition of microfilarial chitinase, a transmission-blocking vaccine candidate antigen, by sera from patients with Brugian and Bancroftian filariasis. Am J Trop Med Hyg 1995 Sep;53(3):289-94."},{"key":"10.1016\/j.provac.2010.11.003_bib0055","doi-asserted-by":"crossref","unstructured":"Li BW, Chandrashekar R, Weil GJ. Vaccination with recombinant filarial paramyosin induces partial immunity to Brugia malayi infection in jirds. J Immunol 1993 Mar 1;150(5):1881-5.","DOI":"10.4049\/jimmunol.150.5.1881"},{"key":"10.1016\/j.provac.2010.11.003_bib0060","doi-asserted-by":"crossref","unstructured":"Maizels RM, Gomez-Escobar N, Gregory WF, Murray J, Zang X. Immune evasion genes from filarial nematodes. Int J Parasitol 2001 Jul;31(9):889-98.","DOI":"10.1016\/S0020-7519(01)00213-2"},{"key":"10.1016\/j.provac.2010.11.003_bib0065","doi-asserted-by":"crossref","unstructured":"Thirugnanam S, Pandiaraja P, Ramaswamy K, Murugan V, Gnanasekar M, Nandakumar K, et al. Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model. Exp Parasitol 2007 Aug;116(4):483-91.","DOI":"10.1016\/j.exppara.2007.02.017"},{"key":"10.1016\/j.provac.2010.11.003_bib0070","doi-asserted-by":"crossref","unstructured":"Veerapathran A, Dakshinamoorthy G, Gnanasekar M, Reddy MV, Kalyanasundaram R. Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis. PLoS Negl Trop Dis 2009; 3(6):e457.","DOI":"10.1371\/journal.pntd.0000457"},{"key":"10.1016\/j.provac.2010.11.003_bib0075","doi-asserted-by":"crossref","unstructured":"Gnanasekar M, Rao KV, He YX, Mishra PK, Nutman TB, Kaliraj P, et al. Novel phage display-based subtractive screening to identify vaccine candidates of Brugia malayi. Infect Immun 2004 Aug;72(8):4707-15.","DOI":"10.1128\/IAI.72.8.4707-4715.2004"},{"key":"10.1016\/j.provac.2010.11.003_bib0080","doi-asserted-by":"crossref","unstructured":"Abraham D, Grieve RB, Holy JM, Christensen BM. Immunity to larval Brugia malayi in BALB\/c mice: protective immunity and inhibition of larval development. Am J Trop Med Hyg 1989 Jun;40(6):598-604.","DOI":"10.4269\/ajtmh.1989.40.598"}],"container-title":["Procedia in Vaccinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877282X10000391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877282X10000391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T11:14:54Z","timestamp":1685877294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877282X10000391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":16,"alternative-id":["S1877282X10000391"],"URL":"https:\/\/doi.org\/10.1016\/j.provac.2010.11.003","relation":{},"ISSN":["1877-282X"],"issn-type":[{"value":"1877-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}